{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:45:40Z","timestamp":1780469140162,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jval.2023.12.010","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T02:06:51Z","timestamp":1703556411000},"page":"301-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease: A Cost-Effectiveness and Value of Information Analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Edna","family":"Keeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.C.","family":"Elwenspoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Roadevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena L.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Everitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair D.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny F.","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/j.gastro.2015.01.044","article-title":"Advances in diagnosis and management of celiac disease","volume":"148","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"issue":"7435","key":"10.1016\/j.jval.2023.12.010_bib2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/bmj.328.7435.322","article-title":"Undiagnosed coeliac disease at age seven: population based prospective birth cohort study","volume":"328","author":"Bingley","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jval.2023.12.010_bib3","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/EDE.0000000000001006","article-title":"Changes in testing for and incidence of celiac disease in the United Kingdom: a population-based cohort study","volume":"30","author":"West","year":"2019","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.jval.2023.12.010_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/ajg.2014.55","article-title":"Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study","volume":"109","author":"West","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jval.2023.12.010_bib5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.281.24.2344","article-title":"Mortality in celiac disease, intestinal inflammation, and gluten sensitivity","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"issue":"9381","key":"10.1016\/j.jval.2023.12.010_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(03)14027-5","article-title":"Coeliac disease","volume":"362","author":"Green","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jval.2023.12.010_bib7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.287.11.1413","article-title":"Risk of non-Hodgkin lymphoma in celiac disease","volume":"287","author":"Catassi","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jval.2023.12.010_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3748\/wjg.14.498","article-title":"Osteoporosis in celiac disease and in endocrine and reproductive disorders","volume":"14","author":"Stazi","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jval.2023.12.010_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"10115","key":"10.1016\/j.jval.2023.12.010_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jval.2023.12.010_bib12","first-page":"583","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"U\u00a0Eur Gastroenterol J"},{"issue":"2","key":"10.1016\/j.jval.2023.12.010_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MPG.0b013e318216f2e5","article-title":"Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report","volume":"54","author":"Giersiepen","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"44","key":"10.1016\/j.jval.2023.12.010_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/ZUCE8371","article-title":"Identifying the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling","volume":"26","author":"Elwenspoek MMC","year":"2022","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","article-title":"State-Transition Modelling: a report of the ISPOR-SMDM Modelling Good Research Practices Task Force-3","volume":"15","author":"Siebert","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2023.12.010_bib16","series-title":"Oxford Handbooks in Health Economic Evaluation","first-page":"237","article-title":"Decision modelling for health economic evaluation","author":"Briggs","year":"2006"},{"issue":"1","key":"10.1016\/j.jval.2023.12.010_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12876-019-0980-6","article-title":"The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective","volume":"19","author":"Violato","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/apt.15109","article-title":"Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities","volume":"49","author":"Fuchs","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jval.2023.12.010_bib19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2036.2008.03609.x","article-title":"Coeliac disease: a biopsy is not always necessary for diagnosis","volume":"27","author":"Hill","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MEG.0000000000000841","article-title":"Coeliac disease: further evidence that biopsy is not always necessary for diagnosis","volume":"29","author":"Holmes","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib21","first-page":"209","article-title":"The serological diagnosis of coeliac disease-a step forward","volume":"11","author":"Holmes","year":"2018","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.cgh.2007.12.008","article-title":"What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis","volume":"6","author":"Hopper","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jval.2023.12.010_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.gastro.2017.04.023","article-title":"Validation of antibody-based strategies for diagnosis of pediatric celiac disease without biopsy","volume":"153","author":"Wolf","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jval.2023.12.010_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041308","article-title":"Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis","volume":"7","author":"Violato","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jval.2023.12.010_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10198-016-0775-4","article-title":"Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort","volume":"18","author":"Wang","year":"2017","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2023.12.010_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bone.2016.03.006","article-title":"Epidemiology of fractures in the United Kingdom 1988-2012: variation with age, sex, geography, ethnicity and socioeconomic status","volume":"87","author":"Curtis","year":"2016","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.jval.2023.12.010_bib27","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00198-015-3277-9","article-title":"Impact of hip fracture on hospital care costs: a population-based study","volume":"27","author":"Leal","year":"2016","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s001980050107","article-title":"The cost of treating osteoporotic fractures in the United Kingdom female population","volume":"8","author":"Dolan","year":"1998","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jval.2023.12.010_bib29","first-page":"1987","article-title":"A\u00a0systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditions","volume":"25","author":"Si","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jval.2023.12.010_bib30","series-title":"Self-Reported Population Health: an International Perspective Based on EQ-5D","first-page":"19","article-title":"Population norms for the EQ-5D","author":"Janssen","year":"2014"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.gastro.2010.05.041","article-title":"Morbidity and mortality among older individuals with undiagnosed celiac disease","volume":"139","author":"Godfrey","year":"2010","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.2006.03203.x","article-title":"Coeliac disease and the risk of fractures-a general population-based cohort study","volume":"25","author":"Ludvigsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jval.2023.12.010_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-7-8","article-title":"Delayed diagnosis of coeliac disease increases cancer risk","volume":"7","author":"Silano","year":"2007","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.jval.2023.12.010_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MEG.0b013e3282f2a5e2","article-title":"Cancer in patients with ulcerative colitis, Crohn\u2019s disease and coeliac disease: record linkage study","volume":"20","author":"Goldacre","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jval.2023.12.010_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bone.2014.06.011","article-title":"Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study","volume":"66","author":"Klop","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jval.2023.12.010_bib36","series-title":"ONS. Cancer Survival in England: Adults Diagnosed Between 2013 and 2017","year":"2018"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jval.2023.12.010_bib39","series-title":"NICE. Coeliac Disease. Full health economics report","year":"2015"},{"key":"10.1016\/j.jval.2023.12.010_bib40","unstructured":"NICE. Developing NICE guidelines: the manual. Process Methods. 2022. Published: 31 October 2014 Last updated: 18 January 2022:[PMG20]. https:\/\/www.nice.org.uk\/process\/pmg20\/chapter\/introduction. Accessed October 10, 2021."},{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40258-021-00664-2","article-title":"Methodological Note: reporting Deterministic versus Probabilistic Results of Markov, partitioned Survival and Other Non-Linear Models","volume":"19","author":"Wilson","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40258-021-00700-1","article-title":"Deterministic and probabilistic analysis of a simple markov model: how different could they be?","volume":"20","author":"Thom","year":"2022","journal-title":"Appl Health Econ Health Policy"},{"issue":"12","key":"10.1016\/j.jval.2023.12.010_bib43","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s40273-018-0697-3","article-title":"Probabilistic sensitivity analysis in cost-effectiveness models: determining model convergence in cohort models","volume":"36","author":"Hatswell","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.jval.2023.12.010_bib44","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/archdischild-2016-312027","article-title":"Barriers to implementing the revised ESPGHAN guidelines for coeliac disease in children: a cross-sectional survey of coeliac screen reporting in laboratories in England","volume":"102","author":"Paul","year":"2017","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jval.2023.12.010_bib45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1524-4733.2008.00358.x","article-title":"Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI)","volume":"11","author":"Barton","year":"2008","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2023.12.010_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jval.2020.01.001","article-title":"Value of information analysis for research decisions-an introduction: report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","volume":"23","author":"Fenwick","year":"2020","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jval.2020.01.004","article-title":"Value of information analytical methods: report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force","volume":"23","author":"Rothery","year":"2020","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0962280211419832","article-title":"Probabilistic sensitivity analysis in health economics","volume":"24","author":"Baio","year":"2015","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"10.1016\/j.jval.2023.12.010_bib49","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0272989X13505910","article-title":"Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: a nonparametric regression approach","volume":"34","author":"Strong","year":"2014","journal-title":"Med Decis Mak"},{"issue":"5","key":"10.1016\/j.jval.2023.12.010_bib50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1177\/0272989X15575286","article-title":"Estimating the expected value of sample information using the probabilistic sensitivity analysis sample: a fast, nonparametric regression-based method","volume":"35","author":"Strong","year":"2015","journal-title":"Med Decis Mak"},{"issue":"2","key":"10.1016\/j.jval.2023.12.010_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0272989X211026305","article-title":"Multilevel and quasi Monte Carlo methods for the calculation of the expected value of partial perfect information","volume":"42","author":"Fang","year":"2022","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.jval.2023.12.010_bib53","series-title":"Age groups","article-title":"gov.uk. UK population by ethnicity","year":"2020"},{"key":"10.1016\/j.jval.2023.12.010_bib54","series-title":"R: A Language and Environment for Statistical Computing","year":"2013"},{"issue":"5","key":"10.1016\/j.jval.2023.12.010_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jval.2019.01.003","article-title":"R\u00a0you still using Excel? the advantages of modern software tools for health technology assessment","volume":"22","author":"Incerti","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2023.12.010_bib56","series-title":"Bayesian Cost-Effectiveness Analysis With the R Package BCEA","author":"Baio","year":"2017"},{"issue":"11","key":"10.1016\/j.jval.2023.12.010_bib57","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2036.2004.01958.x","article-title":"Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis","volume":"19","author":"Mein","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jval.2023.12.010_bib58","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2036.2010.04242.x","article-title":"Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet","volume":"31","author":"Hershcovici","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jval.2023.12.010_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10198-012-0441-4","article-title":"Targeted screening for Coeliac Disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information","volume":"14","author":"Mohseninejad","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2023.12.010_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12876-021-01737-1","article-title":"Is mass screening for coeliac disease a wise use of resources? A health economic evaluation","volume":"21","author":"Norstr\u00f6m","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jval.2023.12.010_bib61","series-title":"Effectiveness and Appropriateness of a Screening Programme","article-title":"Criteria for Appraising the Viability","year":"2015"},{"issue":"4","key":"10.1016\/j.jval.2023.12.010_bib62","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301523062435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301523062435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:37:12Z","timestamp":1761097032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301523062435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1098301523062435"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2023.12.010","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease: A Cost-Effectiveness and Value of Information Analysis","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}